Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

mTOR may link different pathways in hair follicle tumor formation.

Shikimic acid promotes hair growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Researchers made two new compounds that could be used for medicine.

Overexpression of SSAT causes hair loss and skin issues, but reducing putrescine can help.

SARMs work differently in tissues due to unique interactions and structures.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Topical tacrolimus reduces certain growth factors in hair follicles.

Gp₄G promotes hair growth and improves skin health.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The treatment improved hair growth and thickness in most patients with minimal side effects.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Glutamic acid microneedle patches promote better hair growth than traditional treatments.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.